The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis.
about
The aryl hydrocarbon receptor (AHR) transcription factor regulates megakaryocytic polyploidizationTime-Dependent Decay of mRNA and Ribosomal RNA during Platelet Aging and Its Correlation with Translation ActivityCirculating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attackProteasome proteolysis supports stimulated platelet function and thrombosisRelationship between size and thiazole orange fluorescence of platelets in patients undergoing high-dose chemotherapy.Rapid recovery of platelet count following administration of liposome-encapsulated clodronate in a mouse model of immune thrombocytopenia.Reticulated platelets predict platelet count recovery following chemotherapy.Quantitation of reticulated platelets in healthy dogs and in nonthrombocytopenic dogs with clinical disease.Platelet size, platelet surface-associated IgG, and reticulated platelets in dogs with immune-mediated thrombocytopenia.Macrophage depletion following liposomal-encapsulated clodronate (LIP-CLOD) injection enhances megakaryocytopoietic and thrombopoietic activities in mice.Comparison of thrombopoiesis during ITP and HIV-ITP and response to intravenous gammaglobulin treatment.Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia.Usefulness of measurement of reticulated platelets for diagnosis of idiopathic thrombocytopenic purpura.Usefulness of fully automated measurement of reticulated platelets using whole blood.Immature platelet fraction measurement: a future guide to platelet transfusion requirement after haematopoietic stem cell transplantation.Reticulated platelet counts correlate with treatment response in patients with idiopathic thrombocytopenic purpura and help identify the complex causes of thrombocytopenia in patients after allogeneic hematopoietic stem cell transplantation.Rapid platelet turnover in WASP(-) mice correlates with increased ex vivo phagocytosis of opsonized WASP(-) platelets.A prospective evaluation of normal mean platelet volume in discriminating hyperdestructive thrombocytopenia from hypoproductive thrombocytopenia.Flow cytometric analysis of reticulated platelets.Aberrant increase in the immature platelet fraction in patients with myelodysplastic syndrome: a marker of karyotypic abnormalities associated with poor prognosis.New insights into the mechanisms of nonimmune thrombocytopenia in neonates.Immature platelet fraction measurement in patients with chronic liver disease: a convenient marker for evaluating cirrhotic change.Antiplatelet antibodies in WASP(-) mice correlate with evidence of increased in vivo platelet consumption.Complement activation on platelets correlates with a decrease in circulating immature platelets in patients with immune thrombocytopenic purpuraImproved mouse models for the study of treatment modalities for immune-mediated platelet destruction.Mechanism of thrombocytopenia in chronic hepatitis C as evaluated by the immature platelet fraction.Immature platelet fraction in predicting sepsis in critically ill patients.Establishment of reference interval for immature platelet fraction.Absolute immature platelet count may predict imminent platelet recovery in thrombocytopenic children following chemotherapy.Platelet activation and platelet-monocyte aggregate formation contribute to decreased platelet count during acute simian immunodeficiency virus infection in pig-tailed macaquesCombined accurate platelet enumeration and reticulated platelet determination by flow cytometry.Importance of immature platelet fraction as predictor of immune thrombocytopenic purpura.Flow Cytometric Investigation of Classical and Alternative Platelet Activation Markers.Immature platelets do not reliably predict platelet recovery in patients with intensive chemotherapy or stem cell transplantation.Measurements of immature platelets with haematology analysers are of limited value to separate immune thrombocytopenia from bone marrow failure.Reticulated platelet counts in patients undergoing autologous bone marrow transplantation: an aid in assessing marrow recovery.Determination of the percentage of thiazole orange (TO)-positive, "reticulated" platelets using autologous erythrocyte TO fluorescence as an internal standard.Preclinical biology of interleukin 11: a multifunctional hematopoietic cytokine with potent thrombopoietic activity.Quantitation of reticulated platelets: methodology and clinical application.Direct evidence for an increase in thrombopoiesis after liver transplantation.
P2860
Q24627968-0ADD42AE-8EB7-4E76-A5CD-B1EC23DB46ACQ27324375-BF9C174F-4A7C-4633-8FA3-CE28C4C7063EQ28212443-CA166607-FAF2-4BF2-B5FF-DE59FC178CC3Q30580785-71639230-1C4A-4115-9CC8-C154B3D41F9AQ33329714-EA21CEFD-D446-4718-994C-9F0D67C4CDF8Q33341032-80F535C1-5DEE-470D-9216-11C91398A95BQ33342036-BFB6DE28-6AD1-4039-91FC-9B43F54FF537Q33342475-DE7FF5EA-F9E0-49E9-9479-74B0180D648FQ33342521-4F334CDD-D7E3-4EDA-9B6A-3E1CC5057511Q33347254-F9105A3D-14BF-43AD-8382-798250E9DDF5Q33349710-D804119C-B1E5-4D2C-92D7-49498A66EEAEQ33361276-FFED29DB-F681-4351-904C-7367E5ED4C7EQ33367271-8A11218B-59FA-4FEB-9CE1-2A8A8C0DEB00Q33367274-45D98029-E7BB-458F-9CDB-56FDBA97E5A0Q33370895-01C73E46-0E41-4A91-98B3-0A65545F1BFBQ33374085-948D53E4-012C-4F97-944A-61A8498E8EB4Q33378989-FAB064EA-5E0A-4CFB-805C-8BDDC7BBFD6EQ33379833-12A3EDA7-D217-45CA-8C35-52CE3B5EC22AQ33381032-2D8118D4-8D03-4392-9634-A490A3723FE7Q33381215-92100BDF-64E1-4783-AA88-15B66EA2284AQ33382906-18566B5A-E6C5-4DB0-9069-29B053F7D5B7Q33385906-24EA1FE5-C39F-4D48-AF8A-ACCDECCA9DF2Q33386125-CA3426F6-A408-4A00-9EEF-5EF513A1A863Q33387105-9093F55B-4EF9-40E9-A131-71EF9AC21BEFQ33387914-BD4EB673-EA0D-4C44-A677-1C4C32E911F7Q33401841-5C8A88E8-4BAC-4522-85E5-D7EE51BDDEF1Q33403981-330526C0-3709-423E-B76A-C1DFC0D66795Q33405092-0C7711AC-D83B-48CE-BEA7-3F5DE7949617Q33405948-F751DD84-A3CD-4DB9-B0E2-3E2D40CBB771Q33409074-B2457CDA-79CB-4F30-BFF3-B785597013C0Q33421775-EE26054E-C89E-4BAA-8BF6-95488D65DFAFQ33433604-4EE89125-62B1-4883-BCD3-25788CA0073CQ33435650-8BFA6200-B3DD-4518-BD12-1D28D0E6A364Q33438699-A776ADF4-9FE9-4660-B25B-0D1298520ED6Q33440690-DBC73CF7-5C5B-44B2-8241-0E161891AC36Q33491715-A1A19542-D07F-4BA0-9E60-1D0C48CD6A0FQ33494158-A6BAF46F-C374-47A2-A26C-EAB2E590DF64Q33495009-6A178D17-01C2-4E1F-B1AF-1080B17593E0Q33495123-EE0559A9-083E-40FE-80AC-B98BB2CEE3ABQ33503867-43D2C9FE-8B62-4896-B2BD-7ACA42339B73
P2860
The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis.
description
1992 nî lūn-bûn
@nan
1992 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
The significance of platelets ...... of the rate of thrombopoiesis.
@ast
The significance of platelets ...... of the rate of thrombopoiesis.
@en
type
label
The significance of platelets ...... of the rate of thrombopoiesis.
@ast
The significance of platelets ...... of the rate of thrombopoiesis.
@en
prefLabel
The significance of platelets ...... of the rate of thrombopoiesis.
@ast
The significance of platelets ...... of the rate of thrombopoiesis.
@en
P2093
P356
P1476
The significance of platelets ...... of the rate of thrombopoiesis.
@en
P2093
P304
P356
10.1093/AJCP/98.6.637
P407
P577
1992-12-01T00:00:00Z